The relationship between FGF-23 and ghrelin levels in CKD patients: preliminary data.


Ozturk S., Ozkan O., Efe M., Yazici H., Gursu M., Kaya A. H., ...Daha Fazla

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, cilt.68, sa.2, ss.227-32, 2016 (SCI-Expanded) identifier identifier identifier

Özet

BACKGROUND: Fibroblast growth factor (FGF)-23 is a recently discovered phosphaturic hormone that increases in chronic kidney disease (CKD). It has been accepted as a determinant of mortality and a therapeutic target in these patients. Ghrelin is a hormone that has roles in energy and nutrient metabolism. Ghrelin level was found to be increased in CKD patients. This is a controlled study in which the relationship between FGF-23 and ghrelin levels in CKD patients has been studied.